COX-2 inhibition synergizes with radioimmunotherapy by promoting TCF1+CD8+ T cell infiltration in NSCLC
1Department of Radiation Oncology, Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China
2Department of Radiation Oncology, Qilu Hospital of Shandong University, Jinan 250012, China
3Department of Radiation Oncology, Fujian Medical University, Fuzhou 350001, China
收起